In just over a year, Elaine Birkemeyer has transformed the financial position of Tactile Medical, a company devoted to lymphedema, lipedema and chronic venous insufficiency via at-home treatments.

With prices starting at $32.95 per month, you’ll find that Medical Guardian is slightly pricier compared to the competition. But they don’t require you to commit to a long-term contract, unlike other ...

This dramatic reduction in cost, compared to traditional tactile sensors that can run into thousands of dollars ... and precise control capabilities make it particularly promising for healthcare ...

A new report from Aon forecasts a substantial increase in Canadian employer medical costs in 2025, with projected rates rising to 7.4 percent, up from 5.0 percent in 2024. The medical trend rate ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Over the years, Bay Alarm Medical has revolutionized its products to meet the needs and lifestyles of older adults. In our review of Bay Alarm’s alert systems, we found that the company stays on top ...

Amazon One Medical is expanding its telehealth services with the launch of upfront and low-cost treatment plans and medication delivery for several beauty and lifestyle concerns. Customers can get ...

KUALA LUMPUR: The Health Minister has urged private healthcare facilities to take more decisive action to control the escalating cost of medical treatment, which have risen sharply in recent years.

From routine costs — like co-pays at doctor's visits, therapy sessions and prescription medications — to unexpected medical bills, health care expenses weigh heavily on many people's budgets.

Two accounting terms this article will look at are transfer price and standard cost. While an item's standard cost can be used to determine its transfer price, the two values are inherently different.

Leerink analysts said the results were largely in line with outcomes in a trial of Inspire Medical’s rival device but cautioned that Livanova may have a hard time breaking into the sleep apnea market.